NISA INVESTMENT ADVISORS, LLC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$61,754
-31.2%
3,850
-0.5%
0.00%
-100.0%
Q2 2023$89,707
+99574.4%
3,8700.0%0.00%0.0%
Q1 2023$90
+42.9%
3,870
-10.4%
0.00%
Q4 2022$63
-99.9%
4,320
+0.0%
0.00%
-100.0%
Q3 2022$89,000
+15.6%
4,318
+1.4%
0.00%0.0%
Q2 2022$77,000
-54.2%
4,260
-36.0%
0.00%0.0%
Q1 2022$168,000
-8.7%
6,660
-4.9%
0.00%0.0%
Q4 2021$184,000
+23.5%
7,000
+52.2%
0.00%0.0%
Q3 2021$149,000
+5.7%
4,6000.0%0.00%0.0%
Q2 2021$141,000
-28.8%
4,600
-29.2%
0.00%0.0%
Q1 2021$198,000
+53.5%
6,5000.0%0.00%0.0%
Q4 2020$129,000
+89.7%
6,500
+25.0%
0.00%0.0%
Q3 2020$68,000
-29.9%
5,200
-39.3%
0.00%0.0%
Q2 2020$97,000
-15.7%
8,569
+6.8%
0.00%0.0%
Q1 2020$115,000
-58.3%
8,020
-21.0%
0.00%
-50.0%
Q4 2019$276,000
+27.8%
10,150
+34.8%
0.00%0.0%
Q3 2019$216,000
+237.5%
7,530
+224.6%
0.00%
+100.0%
Q2 2019$64,000
-16.9%
2,3200.0%0.00%0.0%
Q1 2019$77,000
+755.6%
2,320
+625.0%
0.00%
Q4 2018$9,000
-40.0%
3200.0%0.00%
Q3 2018$15,000
+36.4%
320
+6.7%
0.00%
Q2 2018$11,000
+22.2%
3000.0%0.00%
Q1 2018$9,0000.0%300
-45.5%
0.00%
Q4 2016$9,000
-83.9%
550
-79.6%
0.00%
-100.0%
Q3 2016$56,000
-16.4%
2,700
+22.7%
0.00%0.0%
Q2 2016$67,000
-28.7%
2,200
-12.0%
0.00%0.0%
Q1 2016$94,0002,5000.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$90,850,0003.94%
Altium Capital Management LP 221,000$4,016,0001.61%
DISCIPLINED GROWTH INVESTORS INC /MN 1,900,787$34,537,0000.93%
Zebra Capital Management LLC 15,352$279,0000.82%
PFM Health Sciences, LP 1,177,250$21,391,0000.82%
EARNEST PARTNERS LLC 6,462,138$117,417,0000.78%
Glenview Capital Management 1,696,791$30,831,0000.77%
AIMZ Investment Advisors, LLC 42,085$765,0000.37%
Phocas Financial Corp. 127,949$2,325,0000.35%
Redhawk Wealth Advisors, Inc. 34,680$630,0000.29%
View complete list of MYRIAD GENETICS INC shareholders